Erratum: Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project) (The Lancet (2017) 390(10112) (2548) (S0140673617324789) (10.1016/S0140-6736(17)32478-9));Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)

The Lancet

Volumn 390, Issue 10112, 2017, Pages 2549-2558

  Lu, Jiapeng ^a   Lu, Yuan ^b   Wang, Xiaochen ^c   Li, Xinyue ^c   Linderman, George C ^b   Wu, Chaoqun ^a   Cheng, Xiuyuan ^c   Mu, Lin ^b   Zhang, Haibo ^a   Liu, Jiamin ^a   Su, Meng ^a   Zhao, Hongyu ^c   Spatz, Erica S ^b   Spertus, John A ^d   Masoudi, Frederick A ^e   Krumholz, Harlan M ^b   Jiang, Lixin ^a  

^a FUWAI HOSPITAL   (China)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c Department of Mathematics ^*  (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; CAPTOPRIL; INDAPAMIDE; IRBESARTAN; METOPROLOL; NIFEDIPINE; NITRENDIPINE; RESERPINE; TELMISARTAN; ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; AWARENESS; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CHINA; COMMUNITY LIVING; DEMOGRAPHY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; EDUCATIONAL STATUS; ETHNICITY; FEMALE; GROUPS BY AGE; HAN CHINESE; HOUSEHOLD INCOME; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; PILOT STUDY; POPULATION RESEARCH; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RURAL AREA; SELF REPORT; SEX DIFFERENCE; SMOKE; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING; URBAN AREA; ATTITUDE TO HEALTH; SEX FACTOR;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; CHINA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; SEX FACTORS;

EID: 85032590502     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)32897-0     Document Type: Erratum

References (30)

1. Chen, Z, Launch of the health-care reform plan in China. Lancet 373 (2009), 1322–1324.
2. Yang, ZJ, Liu, J, Ge, JP, et al. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007–2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J 33 (2012), 213–220.
3. Li, D, Lv, J, Liu, F, et al. Hypertension burden and control in mainland China: analysis of nationwide data 2003–2012. Int J Cardiol 184 (2015), 637–644.
4. Feng, XL, Pang, M, Beard, J, Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ 92 (2014), 29–41.
5. He, J, Gu, D, Chen, J, et al. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet 374 (2009), 1765–1772.
6. Yang, G, Wang, Y, Zeng, Y, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 381 (2013), 1987–2015.
7. Wang, J, Zhang, L, Wang, F, Liu, L, Wang, H, China National Survey of Chronic Kidney Disease Working Group. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens 27 (2014), 1355–1361.
8. Li, W, Gu, H, Teo, KK, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens 34 (2016), 39–46.
9. Lewington, S, Lacey, B, Clarke, R, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med 176 (2016), 524–532.
10. Wang, Z, Wang, X, Chen, Z, et al. Hypertension control in community health centers across China: analysis of antihypertensive drug treatment patterns. Am J Hypertens 27 (2014), 252–259.
11. Yang, L, Yan, J, Tang, X, Xu, X, Yu, W, Wu, H, Prevalence, awareness, treatment, control and risk factors associated with hypertension among adults in southern China, 2013. PLoS One, 11, 2016, e0146181.
12. Gao, Y, Chen, G, Tian, H, et al. Prevalence of hypertension in china: a cross-sectional study. PLoS One, 8, 2013, e65938.
13. Meng, XJ, Dong, GH, Wang, D, et al. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. Journal Hypertens 29 (2011), 1303–1310.
14. Lu, J, Xuan, S, Downing, NS, et al. Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot. BMJ Open, 6, 2016, e010200.
15. James, PA, Oparil, S, Carter, BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311 (2014), 507–520.
16. Liu, LS, Writing Group of Chinese Guidelines for the Management of H. 2010 Chinese guidelines for the management of hypertension. Chin J Cardiol 39 (2011), 579–615.
17. Chobanian, AV, Bakris, GL, Black, HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003), 2560–2572.
18. Zhou, BF, Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. BES 15 (2002), 83–96.
19. National Bureau of Statistics of China. 2010 Population Census of People's Republic of China. http://www.stats.gov.cn/english/Statisticaldata/CensusData/rkpc2010/indexch.htm (accessed April 17, 2017).
20. Egan, BM, Zhao, Y, Axon, RN, US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 303 (2010), 2043–2050.
21. Gu, Q, Burt, VL, Dillon, CF, Yoon, S, Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation 126 (2012), 2105–2114.
22. Yoon, SS, Gu, Q, Nwankwo, T, Wright, JD, Hong, Y, Burt, V, Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension 65 (2015), 54–61.
23. Taylor, J, 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J 34 (2013), 2108–2109.
24. GBD Mortality Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
25. Danaei, G, Finucane, MM, Lu, Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378 (2011), 31–40.
26. Olsen, MH, Angell, SY, Asma, S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 388 (2016), 2665–2712.
27. Luders, S, Schrader, J, Schmieder, RE, Smolka, W, Wegscheider, K, Bestehorn, K, Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil 17 (2010), 271–279.
28. Onysko, J, Maxwell, C, Eliasziw, M, et al. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension 48 (2006), 853–860.
29. Johnson, W, Shaya, FT, Khanna, N, et al. The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population. J Clin Hypertens 13 (2011), 563–570.
30. Su, M, Zhang, Q, Bai, X, et al. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey. Lancet, 2017 published online Oct 25. http://dx.doi.org/10.1016/S0140-6736(17)32476-5.